Home/Investors/Novartis Venture Fund

Novartis Venture Fund

Biotech Investor · 3 portfolio companies

Portfolio

3

Combined Value

$388.6M

Focus Areas

13

Top Stage

Phase 2

Investment Focus

Oncology Anti-infective Cardiovascular Ophthalmology Dementia Central Nervous System Neuromuscular Respiratory Fibrotic Diseases Pulmonary Hepatology Neurology Psychiatry

Portfolio Companies

Company	Stage	Valuation	Focus
Bicycle Therapeutics	Phase 2	$301.8M	Oncology, Anti-infective
Pliant Therapeutics	Phase 2	$79.9M	Fibrotic Diseases, Pulmonary
Addex Therapeutics	Phase 2	$7.0M	Neurology, Psychiatry

Frequent Co-Investors

Public market investors1 shared Atlas Venture1 shared Venrock1 shared Other institutional public market investors1 shared Sofinnova Partners1 shared Aravis Venture1 shared